Check the levels of cobalamin in blood after 4-6 weeks to know the effectiveness of therapy
Still, Ozempic is not a go-to option for most, with only 3 percent of the 15.5 million people using the injectable diabetes drug specifically for weight loss, per a Gallup poll
Retatrutide Phase 3 results look promising, but the drug is not FDA-approved for public use
Researchers are investigating retatrutide as a potential treatment for several metabolic conditions, including[2,3]: Type 2 diabetes Obesity Fatty liver disease Fatty liver disease is commonly linked to obesity, alcohol use, and diabetes
The compound's therapeutic potential stems from its ability to modulate multiple cellular pathways, including extracellular matrix synthesis, metalloproteinase regulation, and inflammatory mediator control
Moriarty, N